Table 4 Independent predictors of compliance with Community Directed Treatment with Ivermectin, Bebeka coffee plantation, Southwest Ethiopia, 2008
Variables | Case No (%) | Control No (%) | COR (95% CI) | AOR* (95% CI) | P-value |
|---|---|---|---|---|---|
Employment status | Â | Â | Â | Â | <0.01 |
   Not-employed | 65 (28.9) | 90 (40.0) | 1.0 | 1.0 |  |
   Employed | 160(71.1) | 135 (60.0) | 1.64 (1.11-2.43) | 1.68 (1.11-2.61) |  |
Perceived risk of having the disease | Â | Â | Â | Â | <0.001 |
   High | 124 (55.1) | 90 (40.0) | 1.84 (1.27-2.68) | 1.98 (1.32-2.95) |  |
   Low | 101 (44.9) | 135 (60.0) | 1.0 | 1.0 |  |
Family supports your intake of ivermectin | Â | Â | Â | Â | Â |
   Yes | 154 (68.4) | 124 (55.1) | 1.77 (1.20-2.60) | 1.86 (1.22-2.84) | <0.001 |
   Not accounted | 71 (31.6) | 101 (44.9) | 1.0 | 1.0 |  |
Perceived performance of community drug distributors | Â | Â | Â | Â | <0.001 |
   Well and very well | 209 (92.9) | 178 (79.1) | 3.45 (1.89-6.23) | 2.84 (1.50-5.37) |  |
   Poor and very poor | 16(7.1) | 47 (20.9) | 1.0 | 1.0 |  |
Measuring height is the best way of dose determination | Â | Â | Â | Â | <0.001 |
   Yes | 221 (98.2) | 194 (87.4) | 7.97 (2.75-23.14) | 6.37 (2.10-19.29) |  |
   No | 4 (1.8) | 28 (12.6) | 1.0 | 1.0 |  |